Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03837353
Title A Parallel Arm Phase 1b/2a Study of DKN-01 as Monotherapy or in Combination With Docetaxel for the Treatment of Advanced Prostate Cancer With Elevated DKK1
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors NYU Langone Health

prostate carcinoma

prostate adenocarcinoma

prostate neuroendocrine neoplasm



DKN-01 + Docetaxel

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.